March 26, 2025 09:58 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rohtak man buries tenant alive in a pit after discovering latter's affair with his wife, body found after 3 months | 'They think it is their birthright to use freedom to tear the country': Yogi Aditnath slams Kunal Kamra | Allahabad HC Bar Association on indefinite strike opposing SC Collegium's transfer of 'cash pile' accused Justice Yashwant Varma | Unwarranted: India on Pakistan's Jammu and Kashmir remark at UN | Abusing people and our culture in the name of comedy: Kangana Ranaut slams Kunal Kamra | Every action has a reaction: Eknath Shinde on vandalism at Mumbai's Habitat Studio over Kunal Kamra joke | 'Will ensure no recurrence': Samay Raina apologises for remarks made on now-deleted show India's Got Latent | Centre hikes salaries, pensions of MPs considering high cost of living | Allahabad HC directs Centre to decide on Rahul Gandhi's dual citizenship row by April 21 | Nagpur communal violence: Suspected mastermind Fahim Khan's house faces bulldozer action

Novavax vaccine gets first emergency use approval in Indonesia: Statement

Nov 02, 2021, at 05:45 am

Jakarta/UNI/Sputnik: US drug maker Novavax said on Monday that the Covid-19 vaccine it jointly developed with the Serum Institute of India has received the first authorization for emergency use in Indonesia.

SII to start production of Russia's Sputnik V vaccine from September

Jul 13, 2021, at 08:38 pm

Pune/IBNS: World's largest vaccine manufacturer, Serum Institute of India (SII), is all set to start the production of Russia's Sputnik V vaccine in India from September, said the CEO of Russian Direct Investment Fund (RDIF), Kirill Dmitriev.

'A new milestone has been reached', says Serum Institute as it starts production of first batch of Covavax

Jun 26, 2021, at 06:18 am

Pune/IBNS: The Serum institute of India, which started manufacturing the first batch of Novavax's Covid-19 vaccine in India under the name Covavax, said "a new milestone has been reached".

Govt's expert panel clears Oxford COVID-19 vaccine for India

Jan 02, 2021, at 03:56 am

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel to meet over Covid-19 vaccine approval today

Jan 01, 2021, at 04:30 pm

New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.

Serum Institute gets DCGI nod to resume Covid-19 vaccine

Sep 16, 2020, at 04:25 pm

New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said. 

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.

Close menu